Education
About Us
Working with TipRanks
Follow Us
James Campbell Insider Profile
4 Followers
James Campbell, Director at Prescient Therapeutics Limited, holds 1.37M shares in Prescient Therapeutics Limited (Ticker: AU:PTX). Most recently, James Campbell Bought 750,000 shares of Prescient Therapeutics Limited on Aug 11, 2025 for an estimated value of AU$30.00K.
James Campbell Prescient Therapeutics Limited (PTX)Director
Prescient Therapeutics Limited (PTX)
Director
Ranked #86,959 out of 103,225 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-30.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that James Campbell holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 11, 2025 - Today
Return:-2.20%
The most profitable trade made by James Campbell
James Campbell's Trading History
List of latest transactions for each holding click on a transaction to see James Campbell's performance on stock
You May Also Like
James Campbell insider profile FAQ
What is the percentage of profitable transactions made by James Campbell?
The percentage of profitable transactions made by James Campbell is 0%.
What is the average return per transaction made by James Campbell?
The average return per transaction made by James Campbell is -30.90%.
What stocks does James Campbell hold?
James Campbell holds: AU:PTX stocks.
What was James Campbell’s latest transaction?
James Campbell latest transaction was an Informative Buy of AU$30.00K.
What was James Campbell's most profitable transaction?
James Campbell’s most profitable transaction was an Informative Buy of AU:PTX stock on August 11, 2025. The return on the trade was -2.20%.
What is James Campbell's role in Prescient Therapeutics Limited?
James Campbell's role in Prescient Therapeutics Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.